Form 4: Dynavax Technologies SVP John L. Slebir Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


John L. Slebir, SVP General Counsel of Dynavax Technologies, reports the vesting of restricted stock units and subsequent tax withholding.

Summary

  • On February 18, 2025, John L. Slebir, SVP General Counsel of Dynavax Technologies, reported transactions involving Dynavax common stock.
  • 16,667 Restricted Stock Units (RSUs) vested, converting into common stock.
  • 5,358 shares were withheld by Dynavax to satisfy tax obligations at a price of $12.93 per share.
  • Following these transactions, Slebir directly owns 36,373 shares of Dynavax common stock and 33,333 RSUs.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing reflecting standard executive compensation practices. It doesn't inherently indicate positive or negative sentiment.

Industry Context

This is a standard SEC Form 4 filing, which is a routine disclosure for corporate insiders reporting changes in their beneficial ownership of company stock. It is a common practice for companies to grant stock options and restricted stock units to executives as part of their compensation packages. The vesting of these equity awards and subsequent tax withholding are typical events.

Stakeholder Impact

  • The transaction has a minor impact on shareholders as it involves the issuance of shares related to executive compensation.

Key Dates

DateDescription
02/15/2024First annual anniversary for RSU vesting (1/3 of RSUs vest)
02/18/2025Date of transaction: Vesting of RSUs and tax withholding
02/21/2025Date of signature on the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.